NEW YORK ( TheStreet) -- Celgene Corporation (Nasdaq: CELG) hit a new 52-week high Thursday as it is currently trading at $135.30, above its previous 52-week high of $131.82 with 1.3 million shares traded as of 9:36 a.m. ET. Average volume has been 3.1 million shares over the past 30 days. Celgene has a market cap of $51.99 billion and is part of the health care sector and drugs industry. Shares are up 59.4% year to date as of the close of trading on Wednesday. Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for cancer and immune-inflammatory related diseases in the United States and Europe.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.